Literature DB >> 19264595

Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly.

Sarah Welbourn1, Vlastimil Jirasko2, Valérie Breton1, Simon Reiss2, Francois Penin3, Ralf Bartenschlager2, Arnim Pause1.   

Abstract

It has been demonstrated that both uncleaved, enzymitically inactive NS2/3 and cleaved NS2 proteins are rapidly degraded upon expression in cells, phenomena described to be blocked by the addition of proteasome inhibitors. As this degradation and its regulation potentially constitute an important strategy of the hepatitis C virus (HCV) to regulate the levels of its non-structural proteins, we further investigated the turnover of these proteins in relevant RNA replication systems. A lysine-mutagenesis approach was used in an effort to prevent protein degradation and determine any effect on various steps of the viral replication cycle. We show that, while NS2-lysine mutagenesis of protease-inactive NS2/3 results in a partial stabilization of this protein, the increased NS2/3 levels do not rescue the inability of NS2/3 protease inactive replicons to replicate, suggesting that uncleaved NS2/3 is unable to functionally replace NS3 in RNA replication. Furthermore, we show that the cleaved NS2 protein is rapidly degraded in several transient and stable RNA replicon systems and that NS2 from several different genotypes also has a short half-life, highlighting the potential importance of the regulation of NS2 levels for the viral life cycle. However, in contrast to uncleaved NS2/3, neither ubiquitin nor proteasomal degradation appear to be significantly involved in NS2 degradation. Finally, although NS2 lysine-to-arginine mutagenesis does not affect this protein's levels in a JFH-1 cell culture infection system, several of these residues are identified to be involved in virion assembly, further substantiating the importance of regions of this protein for production of infectious virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264595     DOI: 10.1099/vir.0.009944-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis.

Authors:  Sergio A Sánchez Manchinelly; Joyce Agati Miller; Ling Su; Tsuyoshi Miyake; Lisa Palmer; Masahito Mikawa; Sarah J Parsons
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Authors:  Maria V Pokrovskii; Caroline O Bush; Rudolf K F Beran; Margaret F Robinson; Guofeng Cheng; Neeraj Tirunagari; Martijn Fenaux; Andrew E Greenstein; Weidong Zhong; William E Delaney; Matthew S Paulson
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.

Authors:  Tung Phan; Rudolf K F Beran; Christopher Peters; Ivo C Lorenz; Brett D Lindenbach
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

5.  Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.

Authors:  Kenneth A Stapleford; Brett D Lindenbach
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

6.  Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein.

Authors:  Cynthia de la Fuente; Zachary Goodman; Charles M Rice
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

7.  The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target.

Authors:  Ivo C Lorenz
Journal:  Viruses       Date:  2010-08-06       Impact factor: 5.818

8.  NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system.

Authors:  Matthew J Bentham; Najat Marraiki; Christopher J McCormick; David J Rowlands; Stephen Griffin
Journal:  J Gen Virol       Date:  2014-07-14       Impact factor: 3.891

9.  Hepatitis C Virus Proteins Interact with the Endosomal Sorting Complex Required for Transport (ESCRT) Machinery via Ubiquitination To Facilitate Viral Envelopment.

Authors:  Rina Barouch-Bentov; Gregory Neveu; Fei Xiao; Melanie Beer; Elena Bekerman; Stanford Schor; Joseph Campbell; Jim Boonyaratanakornkit; Brett Lindenbach; Albert Lu; Yves Jacob; Shirit Einav
Journal:  mBio       Date:  2016-11-01       Impact factor: 7.867

10.  Network-based study reveals potential infection pathways of hepatitis-C leading to various diseases.

Authors:  Anirban Mukhopadhyay; Ujjwal Maulik
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.